Arrowhead Pharmaceuticals Current Cash

Arrowhead Pharmaceuticals (ARWR) currently reports a current cash of $63M as of September 2026. That compares with $230M in the prior-year period — down 72.3% year over year. Use the charts on this page to explore Arrowhead Pharmaceuticals's current cash history and peer comparisons.

Arrowhead Pharmaceuticals's current cash decreased from $230M to $63M — a 72.3% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arrowhead Pharmaceuticals reported $63M in current cash as of September 2026. That compares with $230M in the prior-year period — down 72.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arrowhead Pharmaceuticals, and consider following ARWR for alerts when major investors trade the stock.

Arrowhead Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $63M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARWR with unrelated industries.